Health Care Costs

commentary

Medicare Drug Price Negotiation: Key Decisions to Reach a 'Fair Price'

Government negotiation of Medicare drug prices—even for a small set of older, single-source drugs—is a remarkable policy development. But how exactly will the government do it?

Andrew W. Mulcahy @AndrewWMulcahy

blog

Diversity in the Military, Telemedicine Abortion, China and Taiwan: RAND Weekly Recap

This weekly recap focuses on the benefits of increasing and maintaining diversity in the armed forces, the challenges of telemedicine abortion, whether Indo-Pacific countries are backing China or Taiwan, and more.

blog

Extremism Online, Russia's Military, Preventing Police Killings: RAND Weekly Recap

This weekly recap focuses on the internet's role in stoking extremism and hate, how Russia has failed its military personnel, a research roadmap to help prevent police killings in the United States, and more.

blog

Employing Insurgency in Ukraine, U.S. Hospital Prices, Reaching the Middle Class: RAND Weekly Recap

This weekly recap focuses on how insurgency could give Ukraine an edge over Russia, repurposing commercial buildings to help address L.A.’s housing crisis, Americans’ options for reaching the middle class, and more.

blog

State of the Union 2022: Russia's Invasion of Ukraine and Domestic Policy

In his first State of the Union address, President Joe Biden rebuked Russia for its invasion of Ukraine, aimed to turn a page on the pandemic, and covered a wide range of domestic issues, including mental health care, prescription drug prices, and supporting veterans.

blog

The Most Popular RAND Research of 2021

As another extraordinary year draws to a close, we continue to believe that objective, nonpartisan research and analysis has a key role to play in navigating what continues to be a difficult time. Here are the 10 research projects that resonated most with rand.org readers in 2021.

commentary

Twelve-Month Continuous Eligibility for Medicaid Adults Can Stabilize Coverage with a Modest Cost Increase

Churning—frequent moving in and out of Medicaid due to income fluctuation—increases insurance coverage gaps, disrupts access to health care, increases unnecessary administrative burden, and leads to suboptimal health outcomes. Federal and state policymakers might consider continuous eligibility to help stabilize Medicaid enrollment.

Harry H. Liu, Leighton Ku

commentary

What Are the Practical Considerations for Outcome-Based Payment in the NHS?

Uncertainty can surround the effectiveness or cost-effectiveness of a new medicine, making it difficult to agree on a medicine's price. One solution to avoid unduly delaying or restricting patients' access is to link the medicine's price to the outcomes it produces in a patient. Despite some barriers, outcome-based payment could offer a “win” for patients, the NHS, and industry.

Amanda Cole, Jon Sussex

commentary

Does Vertical Integration Improve or Imperil U.S. Health Care?

Health care consolidation is endemic across the United States. With consolidation has come public attention and regulatory scrutiny. Unfortunately, evidence is accumulating that health care consolidation is harming competition in the U.S. health care market, while neither reducing costs nor improving care.

M. Susan Ridgely

blog

Prescription Drug Prices, Unemployment Insurance, Anti-Asian Racism: RAND Weekly Recap

This weekly recap focuses on lowering prescription drug prices, reforming unemployment insurance, addressing anti-Asian racism, and more.

commentary

How Insurance Marketplace Regulators Can Help Consumers Enroll in Better Coverage

The Affordable Care Act simplified shopping for health care by creating the individual health insurance marketplaces where plans are categorized into labeled tiers. Consumers rely on these labels when comparing plans. But the labels don't tell consumers everything they need to know.

Petra Rasmussen, David M. Anderson

commentary

ACA Subsidies for Higher-Income Families Are Key to Enrolling More Americans

The House Ways and Means Committee has proposed several insurance reforms in its emergency COVID-19 relief package, including increasing subsidizes and extending subsidies to people with higher incomes. The proposed combined approach is a far more efficient means of covering uninsured Americans than enhancing subsidies only for those who are currently eligible.

Christine Eibner @Chrissyeibner

blog

Reducing Hospital Prices, Vaccinating the Most Active, Myanmar: RAND Weekly Recap

This weekly recap focuses on regulating hospital prices to cut spending, a COVID-19 vaccine strategy that prioritizes "active" people, what the Capitol attack means for security clearances, and more.

blog

A Message from Our President, Medical Mistrust, Insulin Prices: RAND Weekly Recap

This weekly recap focuses on Wednesday’s siege on the U.S. Capitol, Americans' psychological distress, medical mistrust and COVID-19 vaccines, and more.

essay

The Astronomical Price of Insulin Hurts American Families

More than 30 million Americans have diabetes, and nearly a quarter of them use insulin to manage their symptoms and prevent life-threatening complications. The price they have to pay for insulin is more than ten times higher than the average prices in 32 other countries combined.